Search

Ile–Trp (IW) and Trp–Leu (WL) are present in enzymatic hydrolysates of whey proteins and act as efficient inhibitors for angiotensin-converting enzyme (ACE) in vitro. Baseline plasma concentrations of IW and WL were analysed to 0.9 ± 0.3 n m for IW and 8.3 ± 1.3 n m for WL. Following administration of 50 mg IW or 100 mg WL to human volunteers (n = 3 for IW and n = 2 for WL, respectively), a significant increase in plasma concentrations to a maximum of 2.4 ± 0.5 n m for IW and 29–36 n m for WL after 0.5 h was observed, followed by rapid elimination. ACE activity in plasma decreased by 32% ± 8% following 50 mg IW administration. Administration of the corresponding amino acids had no effect on ACE activity. Thus, these tryptophan-containing dipeptides may serve as bioactive food additives with beneficial effects for the cardiovascular system.

Bioactive peptides from food proteins such as natural ACE (angiotensin-converting enzyme)-inhibitors have attracted particular attention for their potential to prevent hypertension. ACE-inhibiting peptides were enriched from food protein hydrolysates prepared from α-lactalbumin and lysozyme by selective adsorption on microporous activated carbons. For the eluate, it was shown by liquid chromatography that the strongest inhibitor isoleucyl-tryptophan was enriched by a factor of 11.2 compared to the initial α-lactalbumin hydrolysate. Natural inhibitors derived from lysozyme hydrolysates (e.g., alanyl-tryptophan) were successfully enriched as well. Identification of the enriched peptide fraction by mass spectroscopy revealed the hydrophobic character of the enriched peptides. The molecular weight distribution of the enriched peptide fraction can be controlled by the pore size distribution of the chosen adsorbent, which was proven by size exclusion chromatography of enriched peptide fractions derived from three different model carbons differing in their pore size. The selective enrichment of natural ACE-inhibitors from the α-lactalbumin hydrolysate lead to a 6 times stronger in vitro ACE-inhibition demonstrating the high potential as ingredients for hypotensive functional foods with reduced side effects.

Somatic angiotensin-converting enzyme (ACE) contains two active sites, the C- and N-domain, from which the C-domain is supposed to play a major role in blood pressure regulation and is therefore a promising pharmacological target to reduce blood pressure without side-effects. We report for the first time that tryptophan-containing dipeptides such as Ile-Trp or Val-Trp, which were recently found in food protein hydrolysates, are selective and competitive inhibitors for the C-domain with a selectivity factor of 40 and 70, respectively. Structure-activity studies showed that an N-terminal aliphatic amino acid and a tryptophan moiety in the P2' position are favourable structures for C-domain inhibition in dipeptides. In contrast, the lactotripeptides Ile-Pro-Pro and Val-Pro-Pro, which were widely used as ingredients for hypotensive food, showed a slight selectivity for the N-domain. Hence, tryptophan containing dipeptides are interesting ingredients for functional foods as a natural prevention for hypertension with reduced side effects due to its selective inhibition of the C-domain.

Enzymatic hydrolysis of proteins from rice, soy, pea and wheat, with both chymotrypsin and thermolysin, resulted in hydrolysates, which are efficient inhibitors of the angiotensin-converting enzyme (ACE). IC50 values of the hydrolysates were between 27 and 39mg/l, which is comparable to enzymatically hydrolysed whey protein. A significant increase of the ACE-inhibiting effect was observed following butanol extraction due to accumulation of hydrophobic peptides (IC50 between 12 and 21mg/l). Based on the identification and quantification of individual tryptophan-, tyrosine- and phenylalanine-containing dipeptides, 50-80% of the total ACE-inhibiting potential of butanol extracts from plant protein hydrolysates could be explained. Compared to hydrolysates from whey protein, where the inhibitory effect can almost exclusively be attributed to Ile-Trp, the ACE inhibition by plant protein hydrolysates is caused by a variety of peptides, in particular tyrosine-containing peptides. Hydrolysates of plant proteins are promising ingredients for the development of functional foods.

Bioactive peptides such as Ile-Trp show great potential as natural ACE (angiotensin-converting-enzyme)-inhibitors. A continuous process for the up-scaled enrichment of ACE-inhibiting peptides based on a columnar adsorber system with an activated carbon stationary phase was developed. The particle size of the adsorbent and the flow rate was investigated as key factors affecting adsorption kinetics and separation performance. Batch and column adsorption experiments of model adsorbate systems were successfully transferred to a more complex system of an α-lactalbumin hydrolysate containing a multitude of species. Ile-Trp was successfully enriched from the hydrolysate by a factor of 4 using the optimized carbon column. The enrichment was more selective using smaller adsorbent particles due to improved adsorption kinetics.